Chi, K.N.
BC Cancer Agency
4 papers on CoChat
Most cited papers
- Verified
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide
Noonan, K. L., North, S., Bitting, R. L., Armstrong, A. J., Ellard, S. L., & Chi, K. N. (2013) · Annals of Oncology
Prostate Cancer Treatment and ResearchBone health and treatments
Cited by 343
- Verified
Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events
Smith, M. R., Coleman, R. E., Klotz, L., Pittman, K., Milecki, P., Ng, S., Chi, K. N., Balakumaran, A., Wei, R., Wang, H., et al. (2015) · Annals of Oncology
Bone health and treatmentsProstate Cancer Treatment and Research
Cited by 145
- Verified
Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial
Annala, M., Fu, S., Bacon, J. V. W., Sipola, J., Iqbal, N., Ferrario, C., Ong, M., Wadhwa, D., Hotte, S. J., Lo, G., et al. (2021) · Annals of Oncology
Prostate Cancer Treatment and ResearchBone health and treatments
Cited by 73
- Verified
LBA65 Efficacy of 177Lu-PNT2002 in PSMA-positive mCRPC following progression on an androgen-receptor pathway inhibitor (ARPI) (SPLASH)
Sartor, O., Jiang, D. M., Smoragiewicz, M., Zibelman, M., Flechon, A., El-Haddad, G., Abikhzer, G., Saad, F., Tutrone, R., Tagawa, S. T., et al. (2024) · Annals of Oncology
Radiopharmaceutical Chemistry and ApplicationsProstate Cancer Treatment and Research
Cited by 23
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free